Skip to content

A study for the safety and effectiveness of dark exposure for treatment of refractory amblyopia: a clinical prospective control multicenter trial

A study for the safety and effectiveness of dark exposure for treatment of refractory amblyopia: a clinical prospective control multicenter trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030743
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-04-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory amblyopia

Interventions

group 1:dark exposure and vision training
group2:vision training

Sponsors

Shandong Liangkang Eye Hospital of Purui Group /Children's Eye Diseases and Ocular Motor Institute of Purui Jinan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. The unilateral or bilateral best corrected visual acuity is below the lower limit of the same age; 2. Obvious anomalies but not distinguished ERG; 3. Willing to participate this dark exposure clinical study; 4. Aged from 8 to 55 years old.

Exclusion criteria

Exclusion criteria: 1. Glaucoma; 2. BCVA<0.1; 3. Severe eye diseases; 4. Systemic related diseases; 5. Mental or severe psychological abnormal.

Design outcomes

Primary

MeasureTime frame
best corrective visual acuity;stereoscopic vision;

Secondary

MeasureTime frame
electroretinogram;visual evoked potential;Full field vision;fundus photograph;worth 4 dots test;

Countries

China

Contacts

Public ContactYang Dongsheng

Shandong Liangkang Eye Hospital of Purui Group/Children's Eye Diseases and Ocular Motor Institute of Purui Jinan

0609dsy@yahoo.com+86 13346255098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026